ABVC icon

ABVC BioPharma

5 hedge funds and large institutions have $1.56M invested in ABVC BioPharma in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 6 closing their positions.

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
2
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.26M 372,760 +332,200 +819%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$169K 49,915
VF
3
Virtu Financial
New York
$92K 27,221 +13,329 +96%
UBS Group
4
UBS Group
Switzerland
$26K 7,660 +7,660 New
Morgan Stanley
5
Morgan Stanley
New York
$5K 1,486 +1,486 New
SM
6
Sabby Management
Florida
-71,558 Closed
Squarepoint
7
Squarepoint
New York
-19,207 Closed
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
-15,077 Closed
CS
9
Credit Suisse
Switzerland
-11,709 Closed
TRCT
10
Tower Research Capital (TRC)
New York
-3,492 Closed
Bank of America
11
Bank of America
North Carolina
-494 Closed
CFGS
12
Concourse Financial Group Securities
Alabama